Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency, is a rare autosomal recessive fatty acid oxidation disorder[1] that prevents the body from converting certain fats into energy. This can become life-threatening, particularly during periods of fasting.

Schematic demonstrating mitochondrial fatty acid beta-oxidation and effects of LCHAD deficiency
Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
Other namesLCHAD deficiency
Long-chain 3-hydroxyacyl-coenzyme; A dehydrogenase deficiency has an autosomal recessive pattern of inheritance.

Symptoms

Typically, initial signs and symptoms of this disorder occur during infancy or early childhood and can include feeding difficulties, lethargy, hypoglycemia, hypotonia, liver problems, and abnormalities in the retina. Muscle pain, a breakdown of muscle tissue, and abnormalities in the nervous system that affect arms and legs (peripheral neuropathy) may occur later in childhood. There is also a risk for complications such as life-threatening heart and breathing problems, coma, and sudden unexpected death. Episodes of LCHAD deficiency can be triggered by periods of fasting or by illnesses such as viral infections.

Genetics

Mutations in the HADHA gene lead to inadequate levels of an enzyme called long-chain 3-hydroxyacyl-coenzyme A (CoA) dehydrogenase, which is part of a protein complex known as mitochondrial trifunctional protein. Long-chain fatty acids from food and body fat cannot be metabolized and processed without sufficient levels of this enzyme. As a result, these fatty acids are not converted to energy, which can lead to characteristic features of this disorder, such as lethargy and hypoglycemia. Long-chain fatty acids or partially metabolized fatty acids may build up in tissues and damage the liver, heart, retina, and muscles, causing more serious complications.

Diagnosis

Prognosis

A 2001 study followed up on 50 patients. Of these 38% died in childhood while the rest suffered from problems with morbidity.[2]

gollark: To be honest the phone network and everything associated with it seems terribly designed.
gollark: And there probably will be, since they can hardly vet all of them thoroughly: there are probably a lot of VoIP providers.
gollark: But they *can*, if some provider comes along which is willing to verify a call with a faked number.
gollark: I mean that it seems to require trusting the provider of the other end, i.e. the one the robocaller is subscribed to.
gollark: Which is probably better than now, at least.

See also
  • Medium chain acyl dehydrogenase deficiency

References
  1. Reference, Genetics Home. "LCHAD deficiency". Genetics Home Reference. Retrieved 2017-02-27.
  2. Boer, Margarethe E. J. den; Wanders, Ronald J. A.; Morris, Andrew A. M.; IJlst, Lodewijk; Heymans, Hugo S. A.; Wijburg, Frits A. (2002-01-01). "Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: Clinical Presentation and Follow-Up of 50 Patients". Pediatrics. 109 (1): 99–104. doi:10.1542/peds.109.1.99. ISSN 0031-4005. PMID 11773547.
Classification
External resources


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.